Ngā hua rapu - Matthias Bohn
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke mā Hannelore Ehrenreich, Karin Weißenborn, Hilmar Prange, Dietmar Schneider, Christian Weimar, Katja E. Wartenberg, Peter D. Schellinger, Matthias Bohn, Harald Becker, Martin Wegrzyn, Peter Jähnig, Manfred Herrmann, Michael Knauth, Mathias Bähr, Wolfgang Heide, A. P. Wagner, Stefan Schwab, Heinz Reichmann, G. Schwendemann, Reinhard Dengler, Andreas Kastrup, Claudia Bartels
I whakaputaina 2009Artigo -
2
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial mā Hannelore Ehrenreich, Martin Hasselblatt, Christoph Dembowski, Lukas Cepek, Piotr Lewczuk, Michael Stiefel, Hans-Heino Rustenbeck, N Breiter, Sonja Jacob, Friederike Knerlich‐Lukoschus, Matthias Bohn, W. Poser, Eckart Rüther, Michael M. Kochen, Olaf Gefeller, Christoph H. Gleiter, Thomas Wessel, Marc De Ryck, Loretta M. Itri, Hilmar Prange, Anthony Cerami, Michael Brines, Anna‐Leena Sirén
I whakaputaina 2002Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Engineering
Erythropoietin
Internal medicine
Ischemia
Ischemic stroke
Mechanical engineering
Medicine
Stroke (engine)
Acute stroke
Anesthesia
Biochemistry
Cerebrospinal fluid
Chemistry
Fluid-attenuated inversion recovery
Gene
Intensive care medicine
Magnetic resonance imaging
Modified Rankin Scale
Radiology
Recombinant DNA
Tissue plasminogen activator